Rumiko Shimazawa

1.1k total citations
50 papers, 864 citations indexed

About

Rumiko Shimazawa is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Rumiko Shimazawa has authored 50 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Rumiko Shimazawa's work include Catalytic Cross-Coupling Reactions (5 papers), Catalytic C–H Functionalization Methods (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Rumiko Shimazawa is often cited by papers focused on Catalytic Cross-Coupling Reactions (5 papers), Catalytic C–H Functionalization Methods (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Rumiko Shimazawa collaborates with scholars based in Japan, United States and Czechia. Rumiko Shimazawa's co-authors include Masayuki Ikeda, Ryuichi Shirai, Masami Kuriyama, Yuichi Hashimoto, Tomomi Noguchi, Kazuo Nagasawa, Aya Tanatani, Hiroyuki Miyachi, Osamu Onomura and Masanari Kato and has published in prestigious journals such as Biochemical and Biophysical Research Communications, The Journal of Organic Chemistry and European Journal of Biochemistry.

In The Last Decade

Rumiko Shimazawa

50 papers receiving 835 citations

Peers

Rumiko Shimazawa
Samuel J. Bonacorsi United States
Uwe J. Ries Germany
Rao N. V. S. Mamidi United States
Drago R. Sliskovic United States
Rumiko Shimazawa
Citations per year, relative to Rumiko Shimazawa Rumiko Shimazawa (= 1×) peers Steven M. Pitzenberger

Countries citing papers authored by Rumiko Shimazawa

Since Specialization
Citations

This map shows the geographic impact of Rumiko Shimazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rumiko Shimazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rumiko Shimazawa more than expected).

Fields of papers citing papers by Rumiko Shimazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rumiko Shimazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rumiko Shimazawa. The network helps show where Rumiko Shimazawa may publish in the future.

Co-authorship network of co-authors of Rumiko Shimazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Rumiko Shimazawa. A scholar is included among the top collaborators of Rumiko Shimazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rumiko Shimazawa. Rumiko Shimazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimazawa, Rumiko & Masayuki Ikeda. (2019). Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes. Journal of Pharmaceutical Policy and Practice. 12(1). 30–30. 2 indexed citations
2.
Shimazawa, Rumiko & Masayuki Ikeda. (2017). Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study. Journal of Pharmaceutical Policy and Practice. 10(1). 4–4. 2 indexed citations
3.
Shimazawa, Rumiko & Masayuki Ikeda. (2015). Drug–diagnostic co-development: challenges and issues. Expert Review of Molecular Diagnostics. 16(2). 187–204. 5 indexed citations
4.
Yamaguchi, Yoshiyuki, Hiroki Yamaue, Takuji Okusaka, et al.. (2014). Guidance for peptide vaccines for the treatment of cancer. Cancer Science. 105(7). 924–931. 7 indexed citations
5.
Shimazawa, Rumiko, Ichiro Kusumi, & Masayuki Ikeda. (2011). Delays in psychiatric drug development in Japan. Journal of Clinical Pharmacy and Therapeutics. 37(3). 348–351. 15 indexed citations
7.
Shimazawa, Rumiko, Masami Kuriyama, & Ryuichi Shirai. (2008). Design and synthesis of N-alkyl oxindolylidene acetic acids as a new class of potent Cdc25A inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(11). 3350–3353. 19 indexed citations
8.
Saito, Shintaro, Rumiko Shimazawa, & Ryuichi Shirai. (2004). Diastereoselective Synthesis of D- and L-myo-Inositol 3,4,5,6-Tetrakisphosphates from D-Glucose via Dihydroxylation of (+)-Conduritol B Derivatives. Chemical and Pharmaceutical Bulletin. 52(6). 727–732. 8 indexed citations
9.
Shimazawa, Rumiko, Toshiyuki Suzuki, Kosuke Dodo, & Ryuichi Shirai. (2004). Design and synthesis of dysidiolide analogs from vitamin D3: novel class of Cdc25A inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(12). 3291–3294. 26 indexed citations
10.
Noguchi, Tomomi, Rumiko Shimazawa, Kazuo Nagasawa, & Yuichi Hashimoto. (2002). Thalidomide and its analogues as cyclooxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(7). 1043–1046. 63 indexed citations
11.
Shimazawa, Rumiko, et al.. (1999). Nonpeptide small-molecular inhibitors of dipeptidyl peptidase IV: N-phenylphthalimide analogs. Bioorganic & Medicinal Chemistry Letters. 9(4). 559–562. 23 indexed citations
12.
Shimazawa, Rumiko, Yasuyuki Fujimoto, Masato Komoda, et al.. (1999). Novel Small Molecule Nonpeptide Aminopeptidase N Inhibitors with a Cyclic Imide Skeleton. Journal of enzyme inhibition. 14(4). 259–275. 31 indexed citations
13.
Shimazawa, Rumiko, et al.. (1999). Antiangiogenic Activity of Tumor Necrosis Factor-.ALPHA. Production Regulators Derived from Thalidomide.. Biological and Pharmaceutical Bulletin. 22(2). 224–226. 25 indexed citations
14.
Shimazawa, Rumiko, et al.. (1999). Development of Novel Biological Response Modifiers Derived from Thalidomide.. Journal of Synthetic Organic Chemistry Japan. 57(2). 92–104. 5 indexed citations
15.
Sasaki, Toru, Rumiko Shimazawa, Takayuki Sawada, et al.. (1996). Location of Two Photoaffinity-Labeled Sites on the Ligand-Binding Domain of Retinoic Acid Receptor .ALPHA... Biological and Pharmaceutical Bulletin. 19(5). 659–664. 1 indexed citations
16.
Shimazawa, Rumiko, et al.. (1995). Non-intercalative and sequence-selective interaction of nitropyrene/acridine-skeleton with nucleotides. Application of the dextran-coupling method.. Biological and Pharmaceutical Bulletin. 18(4). 637–639. 4 indexed citations
17.
Sasaki, Tōru, Rumiko Shimazawa, Toru Sawada, et al.. (1995). Determination of the Photoaffinity-Labeled Site on the Ligand-Binding Domain of Retinoic Acid Receptor α. Biochemical and Biophysical Research Communications. 207(1). 444–451. 2 indexed citations
18.
Morisaki, Naoko, Hiroshi Funabashi, Rumiko Shimazawa, et al.. (1993). Effect of side‐chain structure on inhibition of yeast fatty‐acid synthase by cerulenin analogues. European Journal of Biochemistry. 211(1-2). 111–115. 39 indexed citations
19.
Shimazawa, Rumiko, et al.. (1992). Syntheses of Cerulenin and Its Analogs. II. Synthesis and Biological Activity of dl-Carbacerulenin, a Carbocyclic Analog of Cerulenin.. Chemical and Pharmaceutical Bulletin. 40(11). 2954–2957. 7 indexed citations
20.
Shimazawa, Rumiko, et al.. (1991). Fluorescent probes for retinoic acid receptors: Molecular measures for the ligand binding pocket. Biochemical and Biophysical Research Communications. 180(1). 249–254. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026